← Evidence map

ArticleScientific reports2024

Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: patient characteristics from the prospective observational ETNA-AF-China registry.

Xueyuan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 38307927